aap: Withdrawal of Motions for the August 27, 2007 Shareholders’ Meeting

aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment, was intending to table at the Annual General Meeting on August 27 a number of motions in connection with the company’s restructuring and its future focus on biological implants business. The company’s Supervisory Board and Management Board now an-nounce that they will dispense for the time being with votes on the following motions:

• Agenda Item No. 4 - Resolution to change the company’s name
• Agenda Item No. 5 - Resolution to change the company’s purpose
• Agenda Item No. 6 - Resolution to approve a divestiture and takeover agreement
• Agenda Item No. 7 - Resolution to approve an intercompany agreement

aap is planning within the next 12 months to focus the company on the biological implants segment. In their analysis of possible strategic options to spin off or sell the Trauma & Ortho-paedics division, aap Implantate AG’s executive bodies came to the conclusion that transferring this division to a separate subsidiary at the present time might lead to negative fiscal conse-quences arising from the pursuit of individual future alternatives. The Management Board and Supervisory Board intend to present to an extraordinary general meeting to be called at a later date an overall concept that maximizes share value.